Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!
2024-12-19 11:06:52 (6 month(s) ago)
Argenx BV have informed MHRA that the Patient Information Leaflet (PIL) in the affected packs incorrectly contains reference to two subcutaneous injection sites. Only subcutaneous injection to the abdomen is permitted.
